Tekla Capital Management’s GSK GSK Stock Holding History

Tekla Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$1.49M	Hold	41,852	–	–	0.06%	119
2023 Q1	$1.49M	Hold	41,852	–	–	0.06%	131
2022 Q4	$1.47M	Hold	41,852	–	–	0.06%	124
2022 Q3	$1.23M	Buy	+41,852	New	+$1.59M	0.05%	126
2020 Q4	–	Sell	-25,920	Closed	-$1.22M	–	209
2020 Q3	$1.22M	Sell	25,920 -150,290	-85%	-$7.53M	0.05%	173
2020 Q2	$8.98M	Buy	176,210 +10,716	+6%	+$550K	0.34%	62
2020 Q1	$7.84M	Sell	165,494 -40,144	-20%	-$2.14M	0.35%	57
2019 Q4	$12.1M	Buy	205,638 +20,232	+11%	+$1.13M	0.46%	47
2019 Q3	$9.89M	Buy	185,406 +10,446	+6%	+$537K	0.43%	56
2019 Q2	$8.75M	Hold	174,960	–	–	0.36%	63
2019 Q1	$9.14M	Hold	174,960	–	–	0.37%	58
2018 Q4	$8.36M	Hold	174,960	–	–	0.36%	60
2018 Q3	$8.79M	Sell	174,960 -112,240	-39%	-$5.7M	0.32%	70
2018 Q2	$14.5M	Sell	287,200 -28,599	-9%	-$1.44M	0.55%	42
2018 Q1	$15.4M	Buy	315,799 +28,599	+10%	+$1.33M	0.6%	40
2017 Q4	$12.7M	Hold	287,200	–	–	0.49%	45
2017 Q3	$14.6M	Hold	287,200	–	–	0.52%	39
2017 Q2	$15.5M	Hold	287,200	–	–	0.57%	36
2017 Q1	$15.1M	Hold	287,200	–	–	0.59%	36
2016 Q4	$13.8M	Hold	287,200	–	–	0.59%	38
2016 Q3	$15.5M	Sell	287,200 -60,160	-17%	-$3.3M	0.6%	39
2016 Q2	$18.8M	Buy	347,360 +119,360	+52%	+$6.29M	0.77%	32
2016 Q1	$11.6M	Hold	228,000	–	–	0.49%	52
2015 Q4	$11.5M	Hold	228,000	–	–	0.42%	55
2015 Q3	$11M	Buy	+228,000	New	+$11.9M	0.39%	49

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tekla Capital Management's GSK Position: Q2 2023 in Review

Tekla Capital Management held its GSK (GSK) position steady in Q2 2023 at 41,852 shares worth $1.49M. The position accounts for 0.06% of the portfolio, ranked #119.

Tekla Capital Management first reported a position in GSK in Q3 2015 and has held it in 25 quarters since. The position peaked at $18.8M in Q2 2016. 828 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

Tekla Capital Management held 41,852 shares of GSK worth $1.49M as of Q2 2023.
Tekla Capital Management left its GSK share count unchanged in Q2 2023.
GSK made up 0.06% of Tekla Capital Management's portfolio in Q2 2023, its #119 holding.
Tekla Capital Management first reported a position in GSK in Q3 2015 and has held it in 25 quarters since.
Tekla Capital Management's GSK position peaked at $18.8M in Q2 2016.
828 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.